• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 207/08 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms

Patent holdings for IPC class C07D 207/08

Total number of patents in this class: 695

10-year publication summary

46
36
37
47
49
38
41
46
39
33
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
F. Hoffmann-La Roche AG
7946
14
Ligand Pharmaceuticals Incorporated
170
13
Corsair Pharma, Inc.
37
12
Tetraphase Pharmaceuticals, Inc.
51
12
Theravance Biopharma R&D IP, LLC
457
12
Bristol-myers Squibb Company
4840
11
Global Blood Therapeutics, Inc.
183
11
The Regents of the University of California
20153
10
Takeda Pharmaceutical Company Limited
2704
10
Merck Sharp & Dohme LLC
3737
10
Atrogi AB
55
9
Eli Lilly and Company
3898
9
Pfizer Inc.
3396
8
Wave Life Sciences Ltd.
178
8
Theravance, Inc.
66
7
Novartis AG
10707
6
Hoffmann-La Roche Inc.
3489
6
Janssen Pharmaceutica N.V.
3367
6
Ambrx, Inc.
182
6
Biogen MA Inc.
915
6
Other owners 509